When San Angelo local and mother Karenrose Honea’s son was being treated for blood cancer, she often felt isolated and lost. Now, she has a chance to offer the support she wished she had to ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

On April 24, Tommy run the bell at Great Western Hospital and said the magic words: "this bell is here for you to ring, while ...

Ibrahim Aldoss, MD, associate professor, City of Hope, explores recent findings on ponatinib as a first-line treatment for Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

Nancy Delia knows cancer treatment saved her life after she was diagnosed with acute lymphoblastic leukemia (Ph+). But while ...

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

Ibrahim Aldoss, MD, discusses a post hoc analysis of ponatinib in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who did not achieve early MRD negativity.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...